The West Midlands Academic Health Science Network leads, catalyses and drives co-operation, collaboration and productivity between academia, industry, health and care providers and commissioners, and citizens, and accelerates the adoption of innovation to generate continuous improvement in the region’s health and wealth.
This will be achieved in a collaborative environment in which member organisations are mutually supportive and in which the technology-rich West Midlands’ life sciences community is fully integrated and generating additional investment. Innovation will be spread at scale and pace regionally, nationally and internationally. WMAHSN, its partners and the public will celebrate the region’s success as a centre for innovation, health and wealth and as the first digitally-enabled health economy in England. The improved generation and adoption of innovation will benefit the economy by giving the region’s academic institutions and life sciences industry a competitive advantage.
The 100,000 Genomes Project, led by Genomics England in partnership with NHS England, has reached its goal of sequencing 100,000 whole genomes from NHS patients. WMAHSN funds three Genomic Ambassadors to support the work of the 100,000 Genomes Project in… Read More
An adoption supported by the West Midlands Academic Health Science Network is being used by doctors in the West Midlands to help diagnose coronary artery disease. Read More
WMAHSN will be participating with local health practitioners in a national initiative to raise awareness of AF and improve its detection in undiagnosed patients. In this clip from a recent discussion highlighting the initiative and the background to it, WMAHSN's Business Manager Lucy Chatwin and clinical lead for AF Alex Meyer GP, share information about the condition and its incidence. See the full video at http://ow.ly/Wntx30mD4zM.